In exit interviews from the Retatrutide Phase 2 trial, 32 of 36 treated participants reported feeling good about themselves or more self-confident, and 25 reported feeling happier
One of the key molecular sensors driving this adaptation is AMP-activated protein kinase (AMPK)
Just focus on portion control and eating at a comfortable pace
Retatrutide, by activating GLP-1, GIP, and glucagon receptors, may provide faster and more significant weight loss, along with enhanced fat metabolism, giving it a broader metabolic effect compared to semaglutide
People with type 2 diabetes have a 2.5-fold increased risk of ischemic stroke and are 1.5 times more likely to experience hemorrhagic stroke and dementia than those without diabetes (Sarwar et al., 2010
The limited duration and small sample size may have contributed to the lack of behavioral effects, and ongoing trials are exploring repeated dosing strategies (e.g., NCT06252623, NCT06691243)